These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Pearson G; Dewey F; Klein G; Henle G; Henle W J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets. Khyatti M; Stefanescu I; Blagdon M; Menezes J J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus. Yang CS; Hewetson JF Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526 [No Abstract] [Full Text] [Related]
5. Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma. Pearson GR; Qualtiere LF; Klein G; Norin T; Bal IS Int J Cancer; 1979 Oct; 24(4):402-6. PubMed ID: 93578 [TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma. Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366 [TBL] [Abstract][Full Text] [Related]
7. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals. Aya T; Mizuno F; Osato T J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949 [TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development. Jondal M; Gunven P Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292 [TBL] [Abstract][Full Text] [Related]
9. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence. Ernberg I; Klein G; Kourilsky FM; Silvestre D J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906 [No Abstract] [Full Text] [Related]
10. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211 [TBL] [Abstract][Full Text] [Related]
11. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases. Ooka T; de Turenne-Tessier M; Stolzenberg MC Springer Semin Immunopathol; 1991; 13(2):233-47. PubMed ID: 1664988 [No Abstract] [Full Text] [Related]
12. Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma. Granlund DJ; Nkrumah F; Perkins IV; Biggar RJ; Levine PH; Fuccillo DA Int J Cancer; 1979 Nov; 24(5):567-71. PubMed ID: 231015 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus. Levine PH; Ho JH; Nkrumah F; Andrese AP IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411 [No Abstract] [Full Text] [Related]
14. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Qualtiere LF; Pearson GR Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099 [TBL] [Abstract][Full Text] [Related]
15. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746 [TBL] [Abstract][Full Text] [Related]
16. The role of Epstein-Barr virus (EBV) in various human disorders. Hewetson JF South Med J; 1975 Oct; 68(10):1271-3. PubMed ID: 170689 [No Abstract] [Full Text] [Related]
17. The detection of the Epstein-Barr virus (EBV) nuclear antigen (EBNA) by anticomplement immunofluorescence. Immunoglobulin class of antibodies and role of complement. Liabeuf A; Nelson RA; Kourilsky FM Int J Cancer; 1975 Apr; 15(4):533-46. PubMed ID: 166939 [TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies. Sternås L; Luka J; Kallin B; Rosén A; Henle W; Henle G; Klein G J Immunol Methods; 1983 Oct; 63(2):171-85. PubMed ID: 6311908 [TBL] [Abstract][Full Text] [Related]
20. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms. Kurakata S; Ramos OF; Klein G; Klein E Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]